The Cultural Formulation Interview-Engagement Aid
CFI-EA
2 other identifiers
interventional
45
1 country
1
Brief Summary
This study consists of two projects: Project 1: The study team will create and refine the CFI-EA by enrolling 3 clinicians and 9-12 patients to test the CFI-EA's feasibility and acceptability from patient and clinician feedback in a pre-pilot trial. The study team will first train clinicians in the CFI-EA by reading over the CFI-EA treatment manual and practicing how they can use it in behavioral simulations, and then check whether participants think they can do it (feasibility) and like it (acceptability) through standard measures. Following this the study team will revise the CFI-EA based on their feedback for the comparative open trial in Phase 2. Project 2: The study team will test the revised CFI-EA against treatment as usual in a pilot trial. 3 clinicians and 12-15 patients will be enrolled in each arm. As before, the study team will first train clinicians in the revised CFI-EA by reading over the CFI-EA treatment manual and practicing how they can use it in behavioral simulations. Then, the study team will check whether participants think they can do it (feasibility) and like it (acceptability) through standard measures, and in addition will also explore any initial effects on communication behaviors among patients and clinicians and treatment engagement based on treatment retention. The specific aims are: For Project 1:
- 1.To pretest the CFI-EA intervention in a mental health setting through a pre-pilot open trial that explores communication mechanisms of action in terms of communication behavior and cultural content, and
- 2.To revise the CFI-EA intervention based on patient and clinician feedback on its feasibility and acceptability.
- 3.To test the revised CFI-EA's feasibility and acceptability among patients and clinicians in a pilot open trial against treatment as usual, and
- 4.To explore the relationship between the revised CFI-EA's effects on patient-clinician communication and treatment engagement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 20, 2016
CompletedFirst Submitted
Initial submission to the registry
January 30, 2017
CompletedFirst Posted
Study publicly available on registry
February 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 5, 2018
CompletedJanuary 25, 2019
January 1, 2019
2 years
January 30, 2017
January 24, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
CFI-EA feasibility is defined as patient completion rates for all three sessions of the CFI-EA intervention.
CFI-EA feasibility is defined as patient completion rates for all three sessions of the CFI-EA intervention.
two months after the third session
CFI-EA acceptability is defined as patient scores on the CSQ-8.
CFI-EA acceptability is defined as patient scores on the CSQ-8.
the third session
Secondary Outcomes (1)
Treatment engagement defined as the percentage of patients staying within treatment 2 months after the third and last session of the CFI-EA has been delivered.
2 months after the last session of the CFI-EA
Study Arms (3)
Project 1: The Cultural Formulation Interview-Engagement Aid
EXPERIMENTALThe first project is creating the intervention through patient and clinician feedback at JHMC and expert consensus with the K23 mentoring team. The CFI-EA is a list of questions that clinicians can use to customize patient treatment plans based on a cultural competence assessment.
Project 2: The Cultural Formulation Interview-Engagement Aid
EXPERIMENTALIn this arm the study team will test the revised CFI-EA against treatment as usual in a pilot trial.
Project 2: Treatment as usual
ACTIVE COMPARATORTreatment as usual at JHMC consists of clinicians creating treatment plans for patients without any specific training in medical communication or treatment negotiation.
Interventions
Culture affects how all people communicate and understand the world. Culture is important because patients and clinicians from different cultural backgrounds may have different preferences for communication. Mismatch in the clinician's approach and the patient's expectations of care can lead to patient dissatisfaction and discontinuation with treatment. Patients and clinicians may also have different views about what caused an illness, how it functions, what makes it better or worse, and the types of treatment needed. The CFI-EA is a series of questions over three sessions that clinicians can use to clarify patient views about treatment and communication so that patients stay in treatment longer. Clinicians can use the CFI-EA to customize their current treatment plans.
The study team will revise the CFI-EA based on patient and clinician feedback. The study team expects that the revisions will consist of changes to the questions such as adding or subtracting specific items or revising the wording of the content. The study team do not anticipate other changes, though we will let our empirical data analyses guide revisions in consultation with the K23 mentor team.
Eligibility Criteria
You may qualify if:
- Male and female patients aged 18-80; Method of ascertainment: Self-report.
- New patients at JHMC, referred by the intake coordinator; Method of ascertainment: Intake coordinator.
- Willingness and ability to provide written informed consent after full explanation of study procedures. Method of ascertainment: RA informed consent interview that includes a capacity to consent screening form; Clinician referral.
- Racial and ethnic minority (African-American, Latino/Hispanic, Asian-American/Pacific Islander, and Native American). Method of ascertainment: Self-report
You may not qualify if:
- Actively suicidal or homicidal; Method of ascertainment: Self-report and clinician evaluation
- In need of acute detoxification services; Method of ascertainment: Self-report and clinician evaluation
- A condition that interferes with participation (i.e., dementia, mental retardation, or florid psychosis); Method of ascertainment: Clinician evaluation; patients ≥ 65 years of age will participate in a mini-cog exam.
- Caucasian race; Method of ascertainment: self-report
- For Project 2
- Male and female patients aged 18-80; Method of ascertainment: Self-report.
- New patients at JHMC, referred by the intake coordinator; Method of ascertainment: Intake coordinator.
- Willingness and ability to provide written informed consent after full explanation of study procedures. Method of ascertainment: RA informed consent interview that includes a capacity to consent screening form; Clinician referral.
- Racial and ethnic minority (African-American, Latino/Hispanic, Asian-American/Pacific Islander, and Native American). Method of ascertainment: Self-report
- Actively suicidal or homicidal; Method of ascertainment: Self-report and clinician evaluation
- In need of acute detoxification services; Method of ascertainment: Self-report and clinician evaluation
- A condition that interferes with participation (i.e., dementia, mental retardation, or florid psychosis); Method of ascertainment: Clinician evaluation; patients ≥ 65 years of age will participate in a mini-cog exam.
- Caucasian race; Method of ascertainment: self-report
- Patients in Project 1 will be excluded from Participation in Project 2: Method of assessment: self-report and PI/RA evaluation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Flushing Hospital Medical Center
Flushing, New York, 11355, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neil K Aggarwal, M.D.
New York State Psychiatric Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Psychiatrist
Study Record Dates
First Submitted
January 30, 2017
First Posted
February 6, 2017
Study Start
September 20, 2016
Primary Completion
September 5, 2018
Study Completion
September 5, 2018
Last Updated
January 25, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share